Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients. (Q50319740)
Jump to navigation
Jump to search
scientific article published on 2 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients. |
scientific article published on 2 February 2011 |
Statements
1 reference
Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients. (English)
1 reference
Andrew E Arai
1 reference
Peter Kellman
1 reference
Sujethra Vasu
1 reference
W Patricia Bandettini
1 reference
Li-Yueh Hsu
1 reference
Marcus Y Chen
1 reference
Joel Wilson
1 reference
Steve Leung
1 reference
Sujata M Shanbhag
1 reference
O Julian Booker
1 reference
Christine Mancini
1 reference
Jennifer Henry
1 reference
Tracy Lowrey
1 reference
2 February 2011
1 reference
13
1 reference
P124-P124
1 reference
Suppl 1
1 reference
2 February 2011
1 reference
Identifiers
1 reference